Azenta (AZTA) Non-Current Receivables (2012 - 2026)
Azenta's quarterly Non-Current Receivables came in at $45.6 million in Q1 2026, little changed quarter-over-quarter from $45.6 million in Q4 2025.
Azenta has reported Non-Current Receivables for 3 years, with the latest figure at $45.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Receivables changed N/A year-over-year to $45.6 million; the trailing twelve-month figure through Mar 2026 stood at $45.6 million (changed N/A YoY), and the FY2025 full-year result was $45.6 million, changed N/A from the prior year.
- Non-Current Receivables for Q1 2026 stood at $45.6 million, roughly flat from $45.6 million in the prior quarter.
- The five-year high for Non-Current Receivables was $45.6 million in Q3 2025, with the low at $45.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Azenta | 899.66 Mn | 519.15 Mn | 62.04 Mn | 45.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.60 Mn |
| Dec 31, 2025 | 45.60 Mn |
| Sep 30, 2025 | 45.60 Mn |
| Sep 30, 2012 | 3.00 Mn |